Sunshine Biopharma, Inc. (SBFM)
1.15
-0.02
(-1.71%)
USD |
NASDAQ |
Sep 03, 10:01
Sunshine Biopharma Debt to Equity Ratio : 0.0246 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0246 |
| March 31, 2026 | 0.0346 |
| December 31, 2025 | 0.0353 |
| September 30, 2025 | 0.0353 |
| June 30, 2025 | 0.0362 |
| March 31, 2025 | 0.0412 |
| December 31, 2024 | 0.0405 |
| September 30, 2024 | 0.0222 |
| June 30, 2024 | 0.0246 |
| March 31, 2024 | 0.0247 |
| December 31, 2023 | 0.031 |
| September 30, 2023 | 0.0307 |
| June 30, 2023 | 0.0311 |
| March 31, 2023 | 0.0378 |
| December 31, 2022 | 0.0354 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 8.975 |
| September 30, 2021 | -3.011 |
| June 30, 2021 | -2.897 |
| March 31, 2021 | -2.529 |
| December 31, 2020 | -2.004 |
| September 30, 2020 | -1.831 |
| June 30, 2020 | -1.041 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.9056 |
| December 31, 2019 | -0.9731 |
| September 30, 2019 | -1.012 |
| June 30, 2019 | -0.9541 |
| March 31, 2019 | -5.853 |
| December 31, 2018 | -11.88 |
| September 30, 2018 | 20.37 |
| June 30, 2018 | -4.611 |
| March 31, 2018 | -2.732 |
| December 31, 2017 | -1.399 |
| September 30, 2017 | -1.672 |
| June 30, 2017 | -0.6563 |
| March 31, 2017 | -0.9782 |
| December 31, 2016 | -1.130 |
| September 30, 2016 | 0.7719 |
| June 30, 2016 | -2.114 |
| March 31, 2016 | -3.108 |
| December 31, 2015 | -1.911 |
| September 30, 2015 | -1.257 |
| June 30, 2015 | -1.472 |
| March 31, 2015 | -1.358 |
| December 31, 2014 | -1.239 |
| September 30, 2014 | -1.433 |
| June 30, 2014 | -0.8353 |
| March 31, 2014 | -1.170 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 33.63M |
| Total Liabilities (Quarterly) | 6.095M |
| Shareholders Equity (Quarterly) | 27.54M |
| Current Ratio | 5.457 |
| Net Debt Paydown Yield | 1.03% |